Published in Clin Chem on November 27, 2006
Transgenic expression of n-3 fatty acid desaturase (fat-1) in C57/BL6 mice: Effects on glucose homeostasis and body weight. J Cell Biochem (2009) 0.98
A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. J Lipid Res (2008) 0.93
ADEMA: an algorithm to determine expected metabolite level alterations using mutual information. PLoS Comput Biol (2013) 0.83
Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications. Int J Mol Sci (2014) 0.78
Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase. J Lipid Res (2014) 0.77
Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study. Prostaglandins Leukot Essent Fatty Acids (2016) 0.75
Lessons learned from metabolomics in cystic fibrosis. Mol Cell Pediatr (2015) 0.75
The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study. J Cyst Fibros (2016) 0.75
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med (2010) 6.23
Cystic fibrosis. Lancet (2009) 5.40
Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med (2007) 4.34
Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med (2004) 4.09
A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain (2006) 2.91
Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport (2005) 2.75
A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum (2006) 2.74
Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels. Proc Natl Acad Sci U S A (2007) 2.56
Optical measurement of cell membrane tension. Phys Rev Lett (2006) 2.21
A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients. Stroke (2006) 1.91
The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol (2011) 1.64
Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes. J Physiol (2003) 1.59
Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg (2007) 1.54
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics (2007) 1.53
Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response? Pancreatology (2007) 1.52
Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr (2007) 1.48
Clinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain. Eur J Pain (2010) 1.47
A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy. Epilepsia (2006) 1.43
Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr (2012) 1.43
Teaching laboratory management to pathology residents: what skill set are we trying to impart? Am J Clin Pathol (2012) 1.39
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology (2010) 1.33
Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care (2009) 1.25
Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr (2011) 1.23
Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol (2004) 1.23
Evaluation of effectiveness of a computerized notification system for reporting critical values. Am J Clin Pathol (2009) 1.23
Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med (2004) 1.22
Direct Costs of Acute Recurrent and Chronic Pancreatitis in Children in the INSPPIRE Registry. J Pediatr Gastroenterol Nutr (2016) 1.20
Confocal light absorption and scattering spectroscopic microscopy. Appl Opt (2007) 1.18
Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice. J Cell Physiol (2004) 1.17
Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism (2002) 1.17
Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem (2004) 1.16
Platelet activation in cystic fibrosis. Blood (2005) 1.12
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol (2007) 1.12
Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol (2004) 1.09
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol (2008) 1.08
The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet (2005) 1.08
Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr (2005) 1.06
Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front Biosci (2003) 1.04
The peroxisome deficient Arabidopsis mutant sse1 exhibits impaired fatty acid synthesis. Plant Physiol (2004) 1.04
Transcranial DC stimulation coupled with TENS for the treatment of chronic pain: a preliminary study. Clin J Pain (2009) 1.00
Alcoholic pancreatitis in rats: injury from nonoxidative metabolites of ethanol. Am J Physiol Gastrointest Liver Physiol (2002) 1.00
Assessment of critical values policies in Italian institutions: comparison with the US situation. Clin Chem Lab Med (2010) 1.00
Treatment of chronic visceral pain with brain stimulation. Ann Neurol (2005) 0.99
Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res (2008) 0.98
Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med (2002) 0.97
Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet (2003) 0.95
Induction of colitis in cftr-/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol (2004) 0.93
A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. J Lipid Res (2008) 0.93
Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol (2006) 0.92
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids (2007) 0.90
Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab (2005) 0.90
Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr-/- knockout mice. Metabolism (2006) 0.90
Effects of alcohol on hemostasis. Am J Clin Pathol (2005) 0.90
DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity. J Lipid Res (2011) 0.89
Improving doctor-patient communication in the outpatient setting using a facilitation tool: a preliminary study. Int J Qual Health Care (2011) 0.89
Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. J Cyst Fibros (2007) 0.89
Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis. Arch Surg (2006) 0.88
Liver and adipose tissue fatty acid ethyl esters obtained at autopsy are postmortem markers for premortem ethanol intake. Clin Chem (2002) 0.88
Systematic review of early surgery for chronic pancreatitis: impact on pain, pancreatic function, and re-intervention. J Gastrointest Surg (2014) 0.87
Pathogenesis of alcoholic liver disease--recent advances. Alcohol Clin Exp Res (2002) 0.87
Survey of breast-feeding practices and outcomes in the cystic fibrosis population. Pediatr Pulmonol (2004) 0.86
Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res (2002) 0.86
Design and implementation of INSPPIRE. J Pediatr Gastroenterol Nutr (2014) 0.85
Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis. Lipids (2011) 0.84
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis. Biochim Biophys Acta (2011) 0.84
Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.84
Autoimmune pancreatitis. J Gastrointest Surg (2005) 0.84
Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice. J Pediatr Gastroenterol Nutr (2006) 0.83
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis (2010) 0.83
Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol (2003) 0.83
An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology (2003) 0.82
Induction of apoptosis and necrosis in human peripheral blood mononuclear cells by fatty acid ethyl esters. Alcohol Clin Exp Res (2008) 0.82
Enhanced clinical consulting--moving toward the core competencies of laboratory professionals. Clin Chim Acta (2002) 0.82
Novel therapeutic approaches to the treatment of chronic abdominal visceral pain. ScientificWorldJournal (2006) 0.82
Fatty acid ethyl esters. Ethanol metabolites that reflect ethanol intake. Am J Clin Pathol (2003) 0.82
Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatr Pulmonol (2009) 0.82
Combination of D-dimer and amino-terminal pro-B-type natriuretic Peptide testing for the evaluation of dyspneic patients with and without acute pulmonary embolism. Arch Pathol Lab Med (2006) 0.82
Ursodeoxycholic acid in cystic fibrosis-associated liver disease. J Cyst Fibros (2011) 0.81
Red blood cell fatty acid ethyl esters: a significant component of fatty acid ethyl esters in the blood. J Lipid Res (2003) 0.81
Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction. Clin Chim Acta (2005) 0.80
Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery. Am J Pathol (2006) 0.80